Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T01:37:41.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-25T01:36:08.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:20:42.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:52:52.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag v3.7.0 and removes the older v3.6.6, indicating a newer version of the study record has been published.
    Difference
    0.1%
    Check dated 2026-09-20T00:42:05.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    New revision entry v3.6.6 was added to the history, replacing the prior v3.6.5. This reflects a minor platform update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-08-29T20:56:16.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.